4//SEC Filing
Swisher Daniel N JR 4
Accession 0000950170-25-095607
CIK 0001088856other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 4:36 PM ET
Size
8.2 KB
Accession
0000950170-25-095607
Insider Transaction Report
Form 4
Swisher Daniel N JR
Director
Transactions
- Sale
Common Stock
2025-07-10$71.08/sh−2,200$156,376→ 0 total - Exercise/Conversion
Common Stock
2025-07-10$14.08/sh+2,200$30,976→ 2,200 total - Exercise/Conversion
Stock option (right to buy)
2025-07-10−2,200→ 7,700 totalExercise: $14.08Exp: 2028-08-20→ Common Stock (2,200 underlying)
Footnotes (2)
- [F1]The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 1, 2024 in effect at the time of this transaction.
- [F2]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001323113
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 4:36 PM ET
- Size
- 8.2 KB